ID   M3K13_HUMAN             Reviewed;         966 AA.
AC   O43283; B2R6U2; B4DLE3; B4DMV2; B4DZJ4; D3DNU1; Q05BY6; Q15450;
AC   Q2NKN3;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   15-MAR-2017, entry version 148.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 13;
DE            EC=2.7.11.25;
DE   AltName: Full=Leucine zipper-bearing kinase;
DE   AltName: Full=Mixed lineage kinase;
DE            Short=MLK;
GN   Name=MAP3K13 {ECO:0000312|HGNC:HGNC:6852};
GN   Synonyms=LZK {ECO:0000312|EMBL:BAA24817.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAA24817.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   ENZYME REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   AUTOPHOSPHORYLATION.
RC   TISSUE=Cerebellum {ECO:0000269|PubMed:9353328};
RX   PubMed=9353328; DOI=10.1074/jbc.272.45.28622;
RA   Sakuma H., Ikeda A., Oka S., Kozutsumi Y., Zanetta J., Kawasaki T.;
RT   "Molecular cloning and functional expression of a cDNA encoding a new
RT   member of mixed lineage protein kinase from human brain.";
RL   J. Biol. Chem. 272:28622-28629(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 230-340 (ISOFORM 1).
RX   PubMed=8274451;
RA   Schultz S.J., Nigg E.A.;
RT   "Identification of 21 novel human protein kinases, including 3 members
RT   of a family related to the cell cycle regulator nimA of Aspergillus
RT   nidulans.";
RL   Cell Growth Differ. 4:821-830(1993).
RN   [7] {ECO:0000305}
RP   HOMODIMERIZATION.
RX   PubMed=11163770; DOI=10.1016/S0014-5793(00)02432-7;
RA   Ikeda A., Masaki M., Kozutsumi Y., Oka S., Kawasaki T.;
RT   "Identification and characterization of functional domains in a mixed
RT   lineage kinase LZK.";
RL   FEBS Lett. 488:190-195(2001).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH MAPK8IP1.
RX   PubMed=11726277; DOI=10.1093/oxfordjournals.jbchem.a003048;
RA   Ikeda A., Hasegawa K., Masaki M., Moriguchi T., Nishida E.,
RA   Kozutsumi Y., Oka S., Kawasaki T.;
RT   "Mixed lineage kinase LZK forms a functional signaling complex with
RT   JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase
RT   pathway.";
RL   J. Biochem. 130:773-781(2001).
RN   [9] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH PRDX3, AND MUTAGENESIS OF LYS-195.
RX   PubMed=12492477; DOI=10.1046/j.1432-1033.2003.03363.x;
RA   Masaki M., Ikeda A., Shiraki E., Oka S., Kawasaki T.;
RT   "Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB
RT   synergistically.";
RL   Eur. J. Biochem. 270:76-83(2003).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-517; LYS-712 AND LEU-746.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Activates the JUN N-terminal pathway through activation
CC       of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3
CC       to regulate the activation of NF-kappa-B in the cytosol. This
CC       activation is kinase-dependent and involves activating the IKK
CC       complex, the IKBKB-containing complex that phosphorylates
CC       inhibitors of NF-kappa-B. {ECO:0000269|PubMed:11726277,
CC       ECO:0000269|PubMed:12492477, ECO:0000269|PubMed:9353328}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q60700};
CC   -!- ENZYME REGULATION: Activated by autophosphorylation and
CC       homodimerization. {ECO:0000269|PubMed:11163770,
CC       ECO:0000269|PubMed:9353328}.
CC   -!- SUBUNIT: Homodimer; forms dimers through the leucine-zipper motif.
CC       Interacts with the C-terminus of MAPK8IP1 through the kinase
CC       catalytic domain. Binds PRDX3. Associates with the IKK complex
CC       through the kinase domain. {ECO:0000269|PubMed:11163770,
CC       ECO:0000269|PubMed:11726277, ECO:0000269|PubMed:12492477}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1168480, EBI-1168480;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9353328}.
CC       Membrane {ECO:0000269|PubMed:9353328}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O43283-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43283-3; Sequence=VSP_036567, VSP_036568;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC       Name=3;
CC         IsoId=O43283-4; Sequence=VSP_036563, VSP_036566;
CC       Name=4;
CC         IsoId=O43283-5; Sequence=VSP_036562, VSP_036569;
CC       Name=5;
CC         IsoId=O43283-6; Sequence=VSP_036564, VSP_036565;
CC   -!- TISSUE SPECIFICITY: Expressed in the adult brain, liver, placenta
CC       and pancreas, with expression strongest in the pancreas.
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI11727.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=BAG59505.1; Type=Erroneous termination; Positions=740; Note=Translated as Tyr.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB001872; BAA24817.1; -; mRNA.
DR   EMBL; AK296961; BAG59505.1; ALT_SEQ; mRNA.
DR   EMBL; AK297646; BAG60014.1; -; mRNA.
DR   EMBL; AK302951; BAG64106.1; -; mRNA.
DR   EMBL; AK312714; BAG35589.1; -; mRNA.
DR   EMBL; AC099661; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78224.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78225.1; -; Genomic_DNA.
DR   EMBL; BC031677; AAH31677.1; -; mRNA.
DR   EMBL; BC111726; AAI11727.1; ALT_SEQ; mRNA.
DR   EMBL; Z25428; CAA80915.1; -; mRNA.
DR   CCDS; CCDS3270.1; -. [O43283-1]
DR   CCDS; CCDS56298.1; -. [O43283-5]
DR   PIR; I38218; I38218.
DR   RefSeq; NP_001229243.1; NM_001242314.1. [O43283-1]
DR   RefSeq; NP_001229246.1; NM_001242317.1. [O43283-5]
DR   RefSeq; NP_004712.1; NM_004721.4. [O43283-1]
DR   RefSeq; XP_011511612.1; XM_011513310.2. [O43283-1]
DR   RefSeq; XP_016862945.1; XM_017007456.1. [O43283-1]
DR   UniGene; Hs.591306; -.
DR   UniGene; Hs.634586; -.
DR   ProteinModelPortal; O43283; -.
DR   SMR; O43283; -.
DR   BioGrid; 114614; 12.
DR   IntAct; O43283; 3.
DR   MINT; MINT-158088; -.
DR   STRING; 9606.ENSP00000265026; -.
DR   BindingDB; O43283; -.
DR   ChEMBL; CHEMBL1163124; -.
DR   GuidetoPHARMACOLOGY; 2073; -.
DR   iPTMnet; O43283; -.
DR   PhosphoSitePlus; O43283; -.
DR   BioMuta; MAP3K13; -.
DR   PaxDb; O43283; -.
DR   PeptideAtlas; O43283; -.
DR   PRIDE; O43283; -.
DR   Ensembl; ENST00000265026; ENSP00000265026; ENSG00000073803. [O43283-1]
DR   Ensembl; ENST00000424227; ENSP00000399910; ENSG00000073803. [O43283-1]
DR   Ensembl; ENST00000433092; ENSP00000389798; ENSG00000073803. [O43283-6]
DR   Ensembl; ENST00000438053; ENSP00000403561; ENSG00000073803. [O43283-3]
DR   Ensembl; ENST00000443863; ENSP00000409325; ENSG00000073803. [O43283-4]
DR   Ensembl; ENST00000446828; ENSP00000411483; ENSG00000073803. [O43283-5]
DR   GeneID; 9175; -.
DR   KEGG; hsa:9175; -.
DR   UCSC; uc003fph.5; human. [O43283-1]
DR   CTD; 9175; -.
DR   DisGeNET; 9175; -.
DR   GeneCards; MAP3K13; -.
DR   HGNC; HGNC:6852; MAP3K13.
DR   HPA; HPA016497; -.
DR   HPA; HPA036691; -.
DR   HPA; HPA036692; -.
DR   MIM; 604915; gene.
DR   neXtProt; NX_O43283; -.
DR   OpenTargets; ENSG00000073803; -.
DR   PharmGKB; PA30596; -.
DR   eggNOG; KOG4721; Eukaryota.
DR   eggNOG; ENOG410YKX2; LUCA.
DR   GeneTree; ENSGT00760000118807; -.
DR   HOVERGEN; HBG052383; -.
DR   InParanoid; O43283; -.
DR   KO; K04422; -.
DR   OMA; HRRGNSR; -.
DR   OrthoDB; EOG091G0905; -.
DR   PhylomeDB; O43283; -.
DR   TreeFam; TF105119; -.
DR   SignaLink; O43283; -.
DR   SIGNOR; O43283; -.
DR   ChiTaRS; MAP3K13; human.
DR   GeneWiki; MAP3K13; -.
DR   GenomeRNAi; 9175; -.
DR   PRO; PR:O43283; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000073803; -.
DR   CleanEx; HS_MAP3K13; -.
DR   ExpressionAtlas; O43283; baseline and differential.
DR   Genevisible; O43283; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017419; MAP3K12_MAP3K13.
DR   InterPro; IPR027258; MAPKKK13.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR23257:SF560; PTHR23257:SF560; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF038165; MAPKKK12_MAPKKK13; 1.
DR   PIRSF; PIRSF500742; MAPKKK13; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    966       Mitogen-activated protein kinase kinase
FT                                kinase 13.
FT                                /FTId=PRO_0000086264.
FT   DOMAIN      168    409       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     174    182       ATP. {ECO:0000250|UniProtKB:Q12852,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   REGION      433    454       Leucine-zipper 1.
FT   REGION      486    507       Leucine-zipper 2.
FT   REGION      815    828       Acidic. {ECO:0000305}.
FT   ACT_SITE    279    279       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:Q12852,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159,
FT                                ECO:0000255|PROSITE-ProRule:PRU10027}.
FT   BINDING     195    195       ATP. {ECO:0000250|UniProtKB:Q60700,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   VAR_SEQ       1    207       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036562.
FT   VAR_SEQ       1    144       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036563.
FT   VAR_SEQ     122    128       RSGSGSG -> RYLGSAI (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036564.
FT   VAR_SEQ     129    966       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036565.
FT   VAR_SEQ     145    159       IGKAYSTDYKLQQQD -> MSYVECKCLQLENKN (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036566.
FT   VAR_SEQ     159    160       DT -> VF (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036567.
FT   VAR_SEQ     161    966       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036568.
FT   VAR_SEQ     208    220       LRKLKHPNIIAFK -> MYCGIQILALWER (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036569.
FT   VARIANT      44     44       E -> K (in dbSNP:rs35266179).
FT                                /FTId=VAR_051640.
FT   VARIANT     517    517       R -> G (in dbSNP:rs56408536).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040708.
FT   VARIANT     712    712       E -> K (in dbSNP:rs56309231).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040709.
FT   VARIANT     746    746       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040710.
FT   VARIANT     915    915       R -> H (in dbSNP:rs3732576).
FT                                /FTId=VAR_030577.
FT   MUTAGEN     195    195       K->A: Kinase inactive. Fails to activate
FT                                NF-kappa-B.
FT                                {ECO:0000269|PubMed:12492477}.
FT   CONFLICT    106    106       D -> G (in Ref. 2; BAG59505).
FT                                {ECO:0000305}.
FT   CONFLICT    230    232       CII -> YLY (in Ref. 6; CAA80915).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       N -> D (in Ref. 2; BAG59505).
FT                                {ECO:0000305}.
FT   CONFLICT    339    340       FG -> MV (in Ref. 6; CAA80915).
FT                                {ECO:0000305}.
FT   CONFLICT    508    508       E -> G (in Ref. 2; BAG64106).
FT                                {ECO:0000305}.
FT   CONFLICT    821    821       G -> R (in Ref. 2; BAG60014).
FT                                {ECO:0000305}.
SQ   SEQUENCE   966 AA;  108296 MW;  9687F38C8AB20AB1 CRC64;
     MANFQEHLSC SSSPHLPFSE SKTFNGLQDE LTAMGNHPSP KLLEDQQEKG MVRTELIESV
     HSPVTTTVLT SVSEDSRDQF ENSVLQLREH DESETAVSQG NSNTVDGEST SGTEDIKIQF
     SRSGSGSGGF LEGLFGCLRP VWNIIGKAYS TDYKLQQQDT WEVPFEEISE LQWLGSGAQG
     AVFLGKFRAE EVAIKKVREQ NETDIKHLRK LKHPNIIAFK GVCTQAPCYC IIMEYCAHGQ
     LYEVLRAGRK ITPRLLVDWS TGIASGMNYL HLHKIIHRDL KSPNVLVTHT DAVKISDFGT
     SKELSDKSTK MSFAGTVAWM APEVIRNEPV SEKVDIWSFG VVLWELLTGE IPYKDVDSSA
     IIWGVGSNSL HLPVPSTCPD GFKILMKQTW QSKPRNRPSF RQTLMHLDIA SADVLATPQE
     TYFKSQAEWR EEVKKHFEKI KSEGTCIHRL DEELIRRRRE ELRHALDIRE HYERKLERAN
     NLYMELSAIM LQLEMREKEL IKREQAVEKK YPGTYKRHPV RPIIHPNAME KLMKRKGVPH
     KSGMQTKRPD LLRSEGIPTT EVAPTASPLS GSPKMSTSSS KSRYRSKPRH RRGNSRGSHS
     DFAAILKNQP AQENSPHPTY LHQAQSQYPS LHHHNSLQQQ YQQPPPAMSQ SHHPRLNMHG
     QDIATCANNL RYFGPAAALR SPLSNHAQRQ LPGSSPDLIS TAMAADCWRS SEPDKGQAGP
     WGCCQADAYD PCLQCRPEQY GSLDIPSAEP VGRSPDLSKS PAHNPLLENA QSSEKTEENE
     FSGCRSESSL GTSHLGTPPA LPRKTRPLQK SGDDSSEEEE GEVDSEVEFP RRQRPHRCIS
     SCQSYSTFSS ENFSVSDGEE GNTSDHSNSP DELADKLEDR LAEKLDDLLS QTPEIPIDIS
     SHSDGLSDKE CAVRRVKTQM SLGKLCVEER GYENPMQFEE SDCDSSDGEC SDATVRTNKH
     YSSATW
//
